Cite
HARVARD Citation
Jain, T. et al. (2019). Single dose versus multiple doses of rituximab for preemptive therapy of Epstein–Barr virus reactivation after hematopoietic cell transplantation. Leukemia & lymphoma. 60 (1), pp. 110-117. [Online].